Identification of Somatically Acquired <i>BRCA1/2</i> Mutations by cfDNA Analysis in Patients with Metastatic Breast Cancer
Neelima Vidula(Harvard University), Aditya Bardia(UCLA Health), Steven J. Isakoff(Harvard University), Brian Chirn(Harvard University), Richard B. Lanman(Guardant (United States)), Beverly Moy(Massachusetts General Hospital), Laura M. Spring(Massachusetts General Hospital), Seth A. Wander(Harvard University), Lee Zou(Harvard University), Andrzej Niemierko(Harvard University), Antoine Simoneau(Io Therapeutics (United States)), Taronish D. Dubash(Harvard University), Daniel A. Haber(Howard Hughes Medical Institute), Becky Nagy(Guardant (United States)), Brittany A. Reeves(Harvard University), Leif W. Ellisen(Harvard University), A. John Iafrate(Peter MacCallum Cancer Centre), Erica Blouch(Massachusetts General Hospital), Jochen K. Lennerz(Addgene), Shyamala Maheswaran(Massachusetts General Hospital), Michael S. Lawrence(Broad Institute), Mehmet Toner(Shriners Hospitals for Children - Erie), Whijae Roh(Broad Institute), Dejan Juric(Massachusetts General Hospital), Giuliana Malvarosa(Harvard University), Kristen Shannon(Massachusetts General Hospital), Douglas S. Micalizzi(Harvard University), Jerry Younger(Massachusetts General Hospital), Gad Getz(Broad Institute)
Cited by 24
Related Papers
Integrative genomics viewer
|Nature Biotechnology|2011|16.5k
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|Nature|2012|8.5k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k